Enfortumab (Anti-Nectin-4)

Enfortumab (Anti-Nectin-4) is a fully human Kappa monoclonal antibody of IgG1 subtype targeting Nectin-4. The antibody-drug conjugate (ADC) Enfortumab vedotin, sold under the brand name Padcev, is a medicine used primarily for the treatment of urothelial cancer. This ADC drug is a conjugate that combines a monoclonal antibody Enfortumab, linker and a toxic payload monomethyl auristatin E (MMAE). This biosimilar antibody is used for research only. MW: 145.44 kD.

Product Details
Species Reactivity	Human
Host/Isotype	Human IgG1
Class	Monoclonal
Type	Recombinant Antibody
Immunogen	Human Nectin-4
Clone	Enfortumab biosimilar
Conjugate	Unconjugated
Purity	99%
Molecular Weight	145.44 KD
Protein Concentration	1mg/ml
Storage Condition	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Storage Buffer	100mM Pro-Ac, 20mM Arg-Ac, pH 5.0